| [1] | 
													
														FENG Zheng, GUO Qinhao, ZHU Jun, WU Xiaohua, WEN Hao. 
														
															Progress in treatment of gynecological cancer in 2023
														[J]. China Oncology, 2024, 34(4): 340-360.
													 | 
												
																																																																																
													| [2] | 
													
														LI Tong, YANG Huijuan. 
														
															Progress in diagnosis and treatment of mucinous ovarian cancer
														[J]. China Oncology, 2024, 34(1): 90-96.
													 | 
												
																																																																																
													| [3] | 
													
														WANG Hui, WANG Xia, GAO Yi, XU Jing, YU Xiaojuan, FAN Fangqin, DING Yan, KANG Yu. 
														
															Current status and influencing factors of gene screening in first-degree relatives of patients with hereditary breast-ovarian cancer syndrome
														[J]. China Oncology, 2023, 33(5): 499-505.
													 | 
												
																																																																																
													| [4] | 
													
														XIA Lingfang, ZHU Jun, WU Xiaohua. 
														
															The latest progress and prospect of gynecological tumor treatment at 2023 ESMO
														[J]. China Oncology, 2023, 33(11): 969-980.
													 | 
												
																																																																																
													| [5] | 
													
														GUO Qinhao, YU Min, WU Xiaohua. 
														
															Progress in diagnosis and treatment of gynecological tumors in 2022
														[J]. China Oncology, 2023, 33(1): 14-24.
													 | 
												
																																																																																
													| [6] | 
													
														FENG Zheng, WEN Hao. 
														
															Risk-reducing salpingo-oophorectomy for hereditary ovarian cancer
														[J]. China Oncology, 2022, 32(11): 1044-1048.
													 | 
												
																																																																																
													| [7] | 
													
														ZHAO Mingming, WANG Tianyou, WANG Chao. 
														
															Progress in menopausal hormone therapy for postoperative patients with gynecological malignant cancer
														[J]. China Oncology, 2022, 32(11): 1098-1104.
													 | 
												
																																																																																
													| [8] | 
													
														LEI Yajie , GAO Yi , WANG Zhijie , CHENG Xi , YANG Yufei , ZHOU Hongyu , CHEN Lihua , CHEN Yixin , LI Haoran , LI Ziting , WU Xiaohua . 
														
															Potential role of lymphadenectomy in patients with ovarian cancer (ⅠC-ⅡA): a retrospective trial
														[J]. China Oncology, 2021, 31(8): 740-745.
													 | 
												
																																																																																
													| [9] | 
													
														ZHU Jun, WU Xiaohua. 
														
															Leading research progress and prospect of gynecological oncology in 2020
														[J]. China Oncology, 2021, 31(4): 250-256.
													 | 
												
																																																																																
													| [10] | 
													
														CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin. 
														
															Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
														[J]. China Oncology, 2021, 31(4): 330-334.
													 | 
												
																																																																																
													| [11] | 
													
														LIU Yixuan , WEN Zexuan , GUO Lin , LU Renquan . 
														
															The function of TTK1 in platinum-resistant ovarian cancer
														[J]. China Oncology, 2021, 31(3): 182-191.
													 | 
												
																																																																																
													| [12] | 
													
														YU Yi, CONG Qing, XU Congjian, JIANG Wei. 
														
															The effect of PAFR on cisplatin sensitivity in ovarian cancer cells and its mechanism
														[J]. China Oncology, 2021, 31(11): 1063-1071.
													 | 
												
																																																																																
													| [13] | 
													
														WANG Zhihen , MAO Peimin , JIANG Hongyuan , FAN Lingling . 
														
															Assessment of the diagnostic value of CPH-I, CA12-5 and HE4 for cancer prediction in women with ovarian masses with papillary projections diagnosed by ultrasound
														[J]. China Oncology, 2020, 30(8): 599-604.
													 | 
												
																																																																																
													| [14] | 
													
														ZHAO Haiyun, WU Xiaohua. 
														
															Research progress of immunotherapy in ovarian cancer
														[J]. China Oncology, 2020, 30(7): 538-545.
													 | 
												
																																																																																
													| [15] | 
													
														WANG Xiaoqin, FU Xinlei, MA Ruyue, YANG Lina, CHEN Yaping, ZHANG Liwen. 
														
															Sema3A regulates metastasis through epithelial-mesenchymal transition/matrix metalloproteinase-2 in epithelial ovarian cancer
														[J]. China Oncology, 2020, 30(6): 428-434.
													 |